financetom
Business
financetom
/
Business
/
N.Y. court rejects authors' bid to block OpenAI cases from NYT, others
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
N.Y. court rejects authors' bid to block OpenAI cases from NYT, others
Apr 1, 2024 11:54 AM

April 1 (Reuters) - A group of authors suing OpenAI for

copyright infringement in California failed to convince a New

York federal court on Monday to halt related cases brought in

Manhattan by the New York Times, the Authors Guild and others.

U.S. District Judge Sidney Stein said that the writers,

including Michael Chabon, Ta-Nehisi Coates and comedian Sarah

Silverman, did not have a strong enough interest in the New York

cases to justify letting them intervene.

The writers had sought to convince the New York court to

dismiss the cases against OpenAI and Microsoft ( MSFT ),

OpenAI's largest financial backer, or move them to California.

The California court rejected a related request last month.

Representatives for the writers, the New York Times, OpenAI

and Microsoft ( MSFT ) did not immediately respond to requests for

comment. A spokesperson for the Authors Guild declined to

comment.

Several groups of copyright owners have sued major tech

companies over the alleged misuse of their work to train

generative artificial-intelligence systems. The authors in the

California case sued OpenAI last summer, accusing it of using

their books without permission to train the AI model underlying

its popular chatbot ChatGPT.

The Authors Guild filed a similar lawsuit in New York in

September on behalf of other writers including John Grisham and

George R.R. Martin. That lawsuit was followed by additional

complaints from nonfiction authors and the Times.

The California authors told Stein that allowing the

"copycat" cases to continue would lead to inconsistent rulings

and waste resources. But Stein on Monday said that the

California and New York cases had "substantial differences."

"More importantly, for the claims that do overlap, the

California Plaintiffs have no legally cognizable interest in

avoiding rulings that apply to entirely different plaintiffs in

a different district," Stein said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Conocophillips In Advanced Talks To Buy Marathon Oil - FT
BRIEF-Conocophillips In Advanced Talks To Buy Marathon Oil - FT
May 28, 2024
May 29 (Reuters) - Conocophillips ( COP ): * CONOCOPHILLIPS IN ADVANCED TALKS TO BUY MARATHON OIL - FT * CONOCOPHILLIPS IN TALKS TO BUY MARATHON OIL IN A POTENTIAL ALL-STOCK DEAL THAT WOULD VALUE CO AT A LITTLE OVER ITS CURRENT $15BN MARKET VALUE - FT Source text for Eikon: [https://tinyurl.com/eucpbrsw] Further company coverage: ...
Brazil's Congress advances bill to tax low-cost online orders
Brazil's Congress advances bill to tax low-cost online orders
May 29, 2024
BRASILIA (Reuters) - Brazil's lower house of Congress approved on Tuesday the main text of a bill that would enact a new 20% import tax on international online purchases under $50, significantly down from a higher tax rate that was originally proposed. The bill must still be voted on by the Senate. The new import tax rate for purchases that...
BRIEF-Prysmian's Acquisition Of Encore Wire Receives Antitrust Clearance In U.S.
BRIEF-Prysmian's Acquisition Of Encore Wire Receives Antitrust Clearance In U.S.
May 28, 2024
May 29 (Reuters) - Prysmian SpA ( PRYMF ): * ACQUISITION OF ENCORE WIRE RECEIVES ANTITRUST CLEARANCE IN US * TRANSACTION REMAINS SUBJECT TO APPROVAL OF ENCORE WIRE'S SHAREHOLDERS REPRESENTING AT LEAST A MAJORITY OF OUTSTANDING SHARES Further company coverage: (Gdansk Newsroom) ...
PRESS DIGEST- Wall Street Journal - May 29
PRESS DIGEST- Wall Street Journal - May 29
May 28, 2024
May 29 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Merck ( MRK ) is close to a $1.3 billion deal to buy Eyebiotech in cash upfront and make an additional $1.7 billion in milestone payments for the company, which goes...
Copyright 2023-2026 - www.financetom.com All Rights Reserved